|
NAV2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.25939999989977E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.49659999948426E-07 |
| Normal-vs-Stage2 |
1.783990E-04 |
| Normal-vs-Stage3 |
9.62200000009794E-07 |
| Normal-vs-Stage4 |
3.528400E-01 |
| Stage1-vs-Stage2 |
2.594000E-01 |
| Stage1-vs-Stage3 |
5.491400E-01 |
| Stage1-vs-Stage4 |
3.903800E-01 |
| Stage2-vs-Stage3 |
5.185600E-01 |
| Stage2-vs-Stage4 |
5.568000E-01 |
| Stage3-vs-Stage4 |
4.485800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.06759999957329E-07 |
| Normal-vs-AfricanAmerican |
5.43019999965644E-07 |
| Normal-vs-Asian |
1.778030E-02 |
| Caucasian-vs-AfricanAmerican |
8.038000E-01 |
| Caucasian-vs-Asian |
8.054600E-01 |
| AfricanAmerican-vs-Asian |
8.639000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.12099999949322E-07 |
| Normal-vs-Female |
2.1559999999976E-05 |
| Male-vs-Female |
1.068210E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.53210999999098E-05 |
| Normal-vs-Extreme_Weight |
1.20090000055306E-07 |
| Normal-vs-Obese |
5.90450000004239E-07 |
| Normal-vs-Extreme_Obese |
8.79470000159088E-08 |
| Normal_Weight-vs-Extreme_Weight |
6.126400E-01 |
| Normal_Weight-vs-Obese |
9.306800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.988600E-01 |
| Extreme_Weight-vs-Obese |
2.033200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.718400E-01 |
| Obese-vs-Extreme_Obese |
2.914800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.834290E-02 |
| Normal-vs-Age(41-60Yrs) |
6.53039999964911E-07 |
| Normal-vs-Age(61-80Yrs) |
1.41969999978286E-07 |
| Normal-vs-Age(81-100Yrs) |
3.56999999562291E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.929900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.380000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.536130E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.320000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.261500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.783000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.72300000045311E-07 |
| Normal-VS-Type2 PRCC |
2.63580000048336E-08 |
| Normal-VS-KIRP CIMP |
7.138200E-01 |
| Normal-VS-Unclassified PRCC |
1.73578000000063E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.732100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.026300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.056100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.718100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.281400E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
8.543600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.4147000005369E-07 |
| Normal-vs-N1 |
3.96019999999719E-05 |
| Normal-vs-N2 |
8.125400E-01 |
| N0-vs-N1 |
2.201400E-01 |
| N0-vs-N2 |
4.243800E-01 |
| N1-vs-N2 |
4.726000E-01 |
|
|
